oral NKTR

Related by string. Oral NKTR * ORAL . orals . Oral : TULSA Okla. Oral Roberts . hear oral arguments . hears oral arguments . oral arguments . Oral Suspension . Oral Suspension Oral Suspension . Oral Roberts . oral . Oral Fixation Vol . Generex Oral lyn . Oral History . oral cavity . evangelist Oral Roberts / : Nektar Therapeutics NKTR . Nasdaq NKTR . NASDAQ NKTR . oncology NKTR . NKTR * *

Related by context. Frequent words. (Click for all words.) 63 DNA RNA Medicines 63 CK # novel 63 MKC# 63 Nanobody 62 Initiates Phase II 61 ALN TTR 61 liposomal formulation 61 deforolimus 61 INTERCEPT red 60 Aurexis 60 forodesine 60 Initiate Phase 60 CORT # 60 sodium Injection 60 HIV protease inhibitor 59 phase IIa clinical 59 Aerosurf 59 Factor VIIa 59 R sorafenib tablets 59 nitric oxide donating 59 Panzem R 59 refractory chronic lymphocytic 59 MEK inhibitor 58 Mipomersen 58 registrational 58 Phase 2b clinical trials 58 novel antibody therapeutics 58 Traficet EN 58 Belimumab 58 Initiates Phase 58 elotuzumab 58 phase IIb clinical 58 Phase Ib II 58 ongoing Phase 1b 58 CCX# 57 Kuvan R 57 AEG# 57 Azedra 57 Onalta 57 epothilone 57 nicotinic alpha 7 57 subcutaneous formulation 57 MORAb 57 NCCTG 57 Tesetaxel 57 preclinical compounds 57 Shigamabs ® 56 orally bioavailable 56 Phase 1b trial 56 PEG SN# 56 multicenter Phase 56 GLPG# 56 transcriptase inhibitor NNRTI 56 anticancer compound 56 phase Ib 56 HCV protease inhibitor 56 GVAX R 56 investigational compounds 56 multi kinase inhibitor 56 Entereg R 56 Phase 2a 56 CIMZIA TM 56 Diamyd ® 56 Alzhemed TM 56 Presents Positive 56 Dapagliflozin 56 Phase IIIb 56 addressing idiopathic pulmonary 56 pulmonology portfolio 56 polymerase inhibitor 56 Receives Orphan Drug Designation 56 IMC #B 56 antisense drug 55 confirmatory Phase III 55 RGB # 55 phase IIa 55 Completes Enrollment 55 candidate brentuximab vedotin 55 Phase 2a trial 55 talactoferrin 55 Phase 2b study 55 division BioFocus DPI 55 Diamyd R 55 SPC# [001] 55 ALN TTR# 55 Phase Ib clinical 55 relapsed refractory multiple myeloma 55 IND enabling 55 Bicifadine 54 Cethrin 54 Phase 2a clinical 54 Genasense R oblimersen 54 ALN VSP 54 CALAA 54 Phase 2b 54 Phase 1b 54 HER2 positive metastatic breast 54 KNS # 54 Hepatitis C Virus HCV 54 HGS ETR1 54 IIa trial

Back to home page